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Abstract-The immune response to phosphocholine (PC) in mice is highly restricted. Most anti-PC 
antibodies use heavy-chain variable-region (VH) sequences derived from single VH gene segment, VI. In 
order to investigate whether a highly homologous VH gene segment, V/f, could contribute to the 
formation of PC-binding antibodies, we carried out chain recombination experiments with M47A, a 
non-PC binding myeloma protein whose H-chain is encoded by the VII gene segment, and two 
PC-binding antibodies, HPlOl.6G6 (HP6G6) and M5l I. The H-chains from the non-PC-binding 
myeloma protein, M47A, formed a functional PC-binding site when paired with L-chains from both 
PC-binding antibodies. These results suggest that a second VH gene segment, Vll, could theoretically be 
used to form PC-binding antibodies. In addition, these results provide direct evidence that a single H-chain 
can be used in combinatorial association with different L-chains to form antibodies of differing 
specificities 
INTRODUCTION 
The role of germline, somatic and combinatorial 
mechanisms is generating immunoglobulin diversity 
has been studied extensively in the antibody response 
to PC? (Crews et al., 1981., Gearhart et a/., 1981; 
Selsing and Storb, 1981). The response to this small 
hapten is highly restricted (Claflin and Rudikoff, 
1976) and sequence information on murine myeloma 
and hybridoma proteins has shown that most anti-PC 
antibodies use a single type of H-chain sequence 
(VH4) which is paired with one of three different 
types of L-chain sequences (VK8, VK22 or VK24) 
(Barstad et al., 1978). Crews et al. (1981) identified a 
family of four highly homologous VH segments in 
BALB/c mice (designated VI, VIZ, VI3 and V3), and 
they have clearly shown that most anti-PC antibodies 
use VW sequences that are somatically derived from 
a single member of this VH gene family, VI. Re- 
cently, however, several observations have suggested 
that other members of this VH family (VI 1 or V13) 
might be used to generate H-chains of PC-binding 
antibodies. Clarke et al. (1982) reported the sequence 
of a monoclonal anti-PC antibody of CBA/J origin, 
HP101.6G6 (HP6G6), which appears to be derived 
from the CBA/J homologue of VII. A second exam- 
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light; PC, phosphocholine; PCBGG, PC-bovine 
gamma globulin; VI and VI, gene and gene product of 
a VH segment. 
ple of an anti-PC antibody derived from a gene other 
than VI is the BALB/c hybridoma protein HPCG15, 
which has an N-terminal sequence that is more 
closely related to Vll or V13 than it is to VI 
(Gearhart et ul., 1981). There is no known example 
of an anti-PC antibody that uses the precise Vl 1 or 
VI3 germline sequence. The question we wished to 
address was whether the germline Vl 1 VH sequence 
could contribute to the formation of anti-PC anti- 
bodies. Specifically, could an H-chain having the 
germline Vll sequence pair with an appropriate 
L-chain to form a functional PC-binding site? An 
H-chain which has the Vll germline sequence has 
been observed in the non-PC-binding myeloma pro- 
tein M47A (Robinson and Appella, 1979). In order 
to examine the possible role of Vl 1 sequences in the 
formation of a PC-binding site, we carried out chain 
recombination experiments between the H-chain of 
M47A and L-chains from two PC-binding anti- 
bodies. 
The prediction that the M47A H-chain might be 
able to participate in formation of a PC-binding site 
was based on several observations. While the M47A 
VH sequence contains substitutions which are located 
at or near the so-called “contact residues” (Padlan et 
al., 1976), many of these substitutions (positions 30, 
32, 35 and 51) have been observed in the PC-binding 
protein HP6G6 and thus are not incompatible with 
PC-binding (see Fig. 1). The entire H-chain variable 
region of M47A is notably similar to the VH region 
of HP6G6. The M47A sequence differs from HP6G6 
at seven positions in the VH segment. The M47A DH 
segment is the same length as that of HP6G6 and the 
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Fig. I. Comparison of complete VH region scqucnccs 01 
M47A and HP6G6 with BALB:‘c gcrmline encoded se- 
quences. The translated sequences ofBALB,c gene segments 
VI and VII (top two lines) given in single-letter amino acid 
code were determined by Crews et ol. (19811. The t!-an\latcd 
DH sequence (Kurosawa and Tonegawa, 1987). Jl sequence 
(Early vl N(.. 1980) and 33 sequence (Cough and Bernard. 
19811 are also shown. Solid line indicates identity with the 
translated VI or Jl sequence. Amino acid zquence ol 
M47A VW region (Robinson and Appella. 1979) and 
HP6Gh VH regions (Clarke c’t ~1.. 1982) (bottom two lines) 
are compared with the BALB;c germline encodxl sequences. 
Substitutions from VI and JI are noted. Contact residues 
according to Padlan et (I/. (1976) are indicated with it solid 
circle. 
M47A JH sequence is encoded by the same JH gene 
as the HP6G6 JH sequence (JH3). In these experi- 
ments, the M47A H-chain was paired with either 
WP6Gb L-chain or M511 L-chain. Since the M47A 
VH sequence is most closely related to the HPbG6 
VH sequence, we predicted that the HP6Gh L-chain 
would be the most likely L-chain to pair with M47A 
H-chain. The M511 L-chain was selected because it 
has an h’-terminal sequence identical to HP6G6 
L-chain (Clarke S., personal communication). Our 
goal was to determine whether M47A H-chains could 
form a functional PC-binding site with either of these 
L-chains. We measured PC-binding activity in H- and 
L-chain mixtures and not the precise extent of H--I_ 
reassociation because the requirements for recon- 
stitution of binding activity are more rigorous than 
the requirements for formation of a stable re- 
combinant molecule (Barstad el ul.. 1978; Bridges 
and Little, 1971; Kranz and Voss, 1981: Manjula cr 
ul., 1976). We show that the VI l-derived M47A 
H-chain formed a functional PC-binding rc- 
combinant when paired with L-chains from both 
HP6G6 and M511. 
MATERIALS AND METHODS 
My&mu und hvbridoma protrins 
The myeioma cell line M47A was obtained from 
Litton Bionetics Inc. (Kensington, MD). M47A uri- 
nary protein was purified from the urine of BALBjc 
mice (Jackson Laboratory, Bar Harbor, ME) bearing 
subcutaneous M47A tumors as described (Bevan, 
1971). Urine was clarified by centrifugation (3001)) 
concentrated with sucrose and dialyzed extensively 
against distilled water and then against 0.04 M potas- 
sium phosphate buffer (pH 8). The M47A protein 
was then purified by elution from a DEAE-Sephadex 
column (1.5 x S5 cm) in 0.04 A4 potassium phosphate 
buffer (pH 8) as described by Askonas and Will- 
iamson (I 968). The PC-binding myeloma protein, 
M5 I 1. and hybridoma protein HP6Gh were puritied 
from tumor ascites by affinity chromatograph! on 
PC-Sepharose ils described (Claflin and Cubberlq. 
1980). 
A heterologous anti-idiotypic antiserum was made 
against the purified myeloma protein M47.A. A rabbit 
was immunized intradermally (id.) with I mg M47A 
in CFA. Then. 2 weeks later. it received a secondary 
immunization of 1 mp M47A in saline (i.d.). Serum 
was obtained 8 days after secondary immunization. 
The gamma globulin fraction ivas precipitated with 
40”,, ammonium sulfate and then dialyzed against 
PBS. The antlscrum was then absorbed by passage 
o\ter a Sepharose immunoadsorhent column conttrin- 
ing BALBYI normal mouse serum (NMS). The 
BALB:c NMS had been previously absorbed on 
PCSepharose to remove naturally occurring anti-PC 
antibodies. The anti-M47A was also absorbed on a 
Sepharose column to which M51 I. M 167 and M60.3 
myelomrt proteins had been coupled. Absorption ol 
antiserum on these columns wits designed to remove 
activity directed npainst NMS, the x constant region. 
the kappa constant region and any variable-region 
determinants on M5l I. M 167 or M603. The 
specificity of this antiserum was tested by direct 
binding of radiolabelled myeloma proteins and b> 
inhibition assay Mith radiolabelled M47A. 
H- and L-chains were prepared from purified my- 
eloma or hybridoma proteins as described by Bridges 
and Little (1971). A l-ml protein solution containing 
50 mg was dialyzed against 0.?.2/1 Tris -Cl (pH 8.2). 
0.15 M NaCl and 0.002 :\I N+EDTA. Each protein 
was reduced with 0.01 :\/I dithiothreitol for 1 hr and 
alkylated with 0.012 M iodoacetamide for I5 min. 
This reduction and alkylation procedure was per- 
formed twice. Samples were then dialyzed against 
6 M urea and I S acetic acid solvent before acp- 
aration of H- and L-chains by reverse Row 
chromatography on ;I G 100 Sephadex column 
(2.5 x IOOcm) in the urea--acetic acid solvent. The 
M47A H-chain (mol. wt 40,000) and L-chain (mol. wt 
23,000) %ere separated on a larger GIOO Sephadex 
column (2.5 x: 170cm). Separated M47A H-. M47A 
L-, MS1 I H- and M51 I L-chains were stored at 4 C 
in 6 M urea and I :V acetic acid until used in chain 
recombination experiments. The HP6Gh I,-chain was 
dialyzed against 0.01 .lii ammonium bicarbonate 
buffer and stored as lyophilized protein. Puritied 
H- and L-chains were tested for purity bj 
SDS-polyacrylamide gcr electrophoresis 
(SDS-PAGE) as described by Laemmli (1970). The 
M47A H-. M51 I H- and MS1 1 L-chain samples were 
visualized by silver staining as described by Wray CI 
al. (1981). M47A L- and HP6G6 L-chains were 
visualized on a separate gel by staining with 0.0 I”(> 
Coomassie blue. 
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Chain reassoc~ut~o?~ 
Chain reassociation was performed as described by 
Bridges and Little (1971). H- and L-chains were 
mixed in 6 M urea and 1 N acetic acid at an H:L 
absorbancy ratio (280 nm) of approximately 1: 1 as 
indicated. Final protein concn was 50_2OO~g,‘ml. 
Reassociation was achieved by gradual stepwise dia- 
lysis of mixed chains against distilled water then PBS 
at 4’C. Control preparations of H-chain alone or 
L-chain alone were treated similarly. 
Solid-phase radioinmunoussay (SRIA ) 
Direct binding amuy. Chain recombination mix- 
tures were tested for their ability to bind “51-labelled 
PC-BGG in an SRIA. PC-BGG was prepared as 
described (Claflin and Davie. 1975) and iodinated by 
the procedure of Greenwood ef rti. (1963). H-chains, 
L-chains or H + L chain mixtures were used to coat 
polyvinyl chloride microtiter wells (Dynatech Labo- 
ratories, Alexandria, VA) (0.2 mliwell) for 6 hr at 
25C at concns indicated. Protein was aspirated and 
wells were washed 3 times with PBS. Wells were then 
saturated with IO, BSA in PBS for I hr. A 0.2 ml 
solution of ‘%labelled PC-BGG (50,000 cpm) in I’:‘, 
BSA, PBS was added and wells were incubated for 
12-14 hr at 25°C. Unbound PC-BGG was removed 
by aspiration and wells were washed 3 times with 
PBS. The binding of ‘%PC-BGG to protein-coated 
wells was assayed by counting individua1 wells in a 
Packard Auto-Gamma Scintihation Spectrometer. 
Duplicates were run for each binding assay. 
inhibition assay for idiotype. Rabbit anti-M47A 
antiserum at a I: 1000 dilution was used in a solid- 
phase inhibition assay as described by Clafhn and 
Davie (1975). Binding of ‘“51-labelled M47A 
(50,00Ocpm/ml) in the presence of unlabelled in- 
hibitor protein was measured. 
RESULTS 
Pur$cation qf H- and L-chains 
The GlOO-Sephadex separation resulted in quan- 
titative yields of H- and L-chains from each parent, 
including M47A, indicating that the unusual covalent 
bond between M47A H- and L-chains (Robinson and 
Appella, 1979) was e~ciently reduced under these 
conditions. Results of an SDS-polyacrylamide gel of 
M47A H, M511 H and M511 L are shown in Fig. 2. 
Titration of each sample at several concns showed 
Fig. 2. SDS--PAGE analysis of separated H- and L-chains. Separated H- and L-chains were analyzed in 
a 10% polyacrylamide gel containing 0.1”) 10 SDS and 8 A4 urea. Gel was run for 5 hr at 20 mA. Polypeptides 
were visualized using silver-staining procedure as described by Wray et al. (1981). Lane 1, M47A H: 5 pg: 
lane 2. M47A H: 1 Ltg; lane 3, M51 1 H: 8jig; lane 4. MS1 1 H: 1.5pg; lane 5. M51 1 L: 1 pg: and lane 
6. MS 1 I L: 0.2 pg. 
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Fig. 3. Homologous recombination of MS1 I H and M51 I L: direct binding of “‘I-PC--BGG. M51 1 
H-chains and M5f I L-chains were mixed while in urea-acetic acid solvent at an H: L absorbance ratio 
at 280 nm of 1: I. Final protein concn after dialysis of H + L mixture was 163 ~~g/rnl. Homologous mixture 
(H + L), M511 H or MS1 I L at concns indicated were tested for the ability to bind “‘I-PC-BGC in a 
direct SRIA as described in Materials and Methods. Each point is the average of duplicate determinations. 
M511 H+MSll L (e--a). M511 H (O- 0). M511 L (C1----n). 
that individual chains contained less than 1”; con- 
tamination. The M47A H-chain had an apparent 
mol. wt of approximately 40,000 which is consistent 
with previous observations of Robinson and Appella 
(1979) who found that the M47A H-chain lacked the 
CH3 domain. Preparations of M47A L, HP6G6 H 
and HP6G6 L had less than 5”/, contamination as 
estimated from Coomassie blue stained SDS-PAGE 
(data not shown). 
Homologous chain mixtures 
The ability of separated chains to recombine and 
form functional molecules was first tested by mixing 
homologous chains, i.e. H- and L-chains derived 
from the same parental molecule. The M5 11 H-chain 
was mixed with M511 L-chain while in urea-acetic 
acid solvent, dialyzed and then tested for the ability 
to bind “‘1-PC-BGG as described in Materials and 
Methods. In these experiments, we were principally 
concerned with the reconstitution of functional bind- 
ing sites and not the extent of H-L association. 
Results of homologous recombination are shown in 
Fig. 3. The separated chains did not demonstrate any 
detectable binding activity. Thus, the purified chains 
did not contain any intact molecules or con- 
taminating chains that could yield a detectable re- 
combinant upon dialysis. The level of binding of the 
mixture of M51 I H + M51i L was approximately 
80% of the binding activity observed for the reduced 
and alkylated parent molecule. Thus, separated M51 I 
H- and L-chains were capable of efficient re- 
combination to form a functional PC-binding site. 
Separated H- and L-chains from the myetoma 
protein M47A were then tested for their ability to 
form a homologous recombinant. Since the M47A 
protein has no known binding activity, the ability to 
recombine was tested by the reconstitution of M47A 
idiotypic determinants. The anti-M47A idiotypic an- 
tiserum used to monitor recombination reacted exclu- 
sively with M47A and showed no activity toward 
M511 (IgA, ti) or HP6G6 (IgM, K) which possess 
CH, CK or VH regions similar to M47A (see Fig. 4). 
The homologous recombination mixture of M47A 
H + M47A L inhibited binding of ““I-M47A (native) 
to this anti-idiotypic antiserum. and the level ol 
inhibition was the same as that observed with a 
reduced and alkylated preparation of the parent 
M47A. Individual M47A H-chains or M47A L- 
chains showed some ability to inhibit; however, they 
had 4- to l&fold lower activity. respectively, in this 
assay. These results demonstrate that the mixing of 
M47A H- and L-chains is accompanied by a recon- 
stitution of idiotypic determinants indicating that 
M47A H and M47A L are able to recombine to form 
a molecule which is idiotypicaily similar to intact 
M47A. 
Heterologous chain mixtures 
To determine whether M47A H-chain, containing 
Vi l-derived sequences, could form a functional rc- 
combinant with the L-chain from a PC-binding anti- 
body, the M47A H-chain was paired with either the 
HP6G6 L-chain or the M511 L-chain. The first step 
in the heterologous recombination experiments was 
to demonstrate that the HP6G6 L-chain was func- 
tional. Homologous recombination between WP6G6 
H and HP6G6 L did not result in formation of a 
functional molecule due to the insoiubilit~ OF the 
HP6G6 H-chain. As an alternative approach, a pre- 
liminary experiment was performed which combined 
Heterologous H/L recombinants i63 
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Fig. 4. Homologous recombination of M47A H and M47A 
L: expression of M47A idiotypic determinants. Inhibition 
SRIA as described in Materials and Methods was used to 
examine the expression of M47A idiotypic determinants on 
individual M47A H-chains, M47A L-chains or M47A 
H + L mixture. M47A H-chains were mixed with M47A 
L-chains in urea-acetic acid solvent at an H : L absorbance 
ratio at 280nm of 1:2. Final protein concn in H + L 
mixture after dialysis was 65 pgg/ml. The binding of 
“‘I-M47A (50,000 cpmiml) to anti-M47A at I : 1000 
was inhibited by unlabelled proteins as follows; HP6G6 
(O-O), M51 I (a---•), M47A H-chain (x-x), 
M47A L-chain (n---n), M47A H + M47A L (m---W). 
reduced + alkylated M47A (A-&, intact M47A 
(0-U). 
H-chain was used under identical conditions (com- 
pare Fig. 5A and B). 
Further experiments pairing M47A H-chain with 
M511 L-chain gave results similar to those obtained 
with M47A H + HP6G6 L (see Fig, SC). The PC- 
binding activity for the M47A H + M51 I L mixtures 
was comparable to that of M47A H + HP6G6 L. The 
ratio of H : L (1: 1 or 2 : 1) had no apparent effect on 







HP6G6 L-chain with M511 H-chain. This H-chain, 
unlike HP6G6 H-chain, retains its solubility when 
separated from the parent molecule. The result of 
heterologous recombination of M5 11 H and HP6G6 
L is shown in Fig. 5A. The H + L mixture showed 
significant PC-binding activity while individual H- or 
L-chains did not show any detectable binding. The 
activity observed with this heterologous re- 
combination was similar to that seen in the homolo- 
gous recombination of M511 H with M511 L (com- 
pare Figs 5A and 3). 
When M47A H was paired with HP6G6 L-chain 
under identical experimental conditions a slightly 
different result was obtained (Fig. 5B). Individual H- 
or L-chains alone, treated the same as H + L mix- 
tures, showed no detectable activity. When M47A 
H-chains were mixed with HP6G6 L-chains, PC- 
binding activity was reconstituted. The control ex- 
periment of M47A H + M47A L did not show any 
PC-binding activity, indicating that the HP6G6 L- 
chain was necessary for the reconstitution of a func- 
tional binding site. It is important to note, however, 
that the level of PC-binding which was reconstituted 
in the heterologous mixture of M47A H + HP6G6 L 
is less than 10::: of the activity observed when MS1 1 
L I 1 , ! 
1 10 100 I,oOC 
Protein cont. ug ml 
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Fig. 5. Heterologous recombinations: direct binding of 
“51-PC-BGG. Direct SRIA binding assay was used to 
examine the binding of “‘I-PC-BGG (250,000 cpmiml) to 
individual H-chains, L-chains or H + L mixtures. Back- 
ground counts bound in the absence of protein sample were 
approximately 200 cpm. Total cpm bound are indicated. (A) 
MS1 1 H-t HP6G6 L: MS11 H-chains were mixed with 
HP6G6 L-chains at an H:L absorbance ratio at 280 nm of 
1: 1. Final protein concn after dialysis was 200 qg/ml. M5! I 
H + HP6G6 L (O---O), M511 H (a---n), HP6G6 L 
(O--O). (B) M47A H + HP6G6 L: M47A H-chains were 
mixed with HP6G6 L-chains at an H : L absorbance ratio of 
1: 1. Final protein concn after dialysis was 173 pg/ml. M47A 
H + HP6G6 L (O---O), HP6G6 L (n---n). M47A H 
(O---O), M47A H+ M47A L (A---A). (C) M47A 
H + M511 L: M47A H-chains were mixed with M511 
L-chains at an H: L absorbance ratio of either 1: 1 or 2: I. 
Final protein concn was 125%180pg/mI. M47A H + M51 I 
L, 1: I (A----D): M47A H + M511 L, 2: I (m---m); 
M47A H (O-O), M511 L (O--O). 
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DISCUSSION 
The goal of these experiments was to determine 
whether the germline Vll sequence could participate 
in the formation of a PC-binding antibody. Our 
results show that the M47A W-chain, which contains 
the VI 1 germline sequence, is able to form a PC- 
binding site when paired with either HP6G6 L-chains 
or M51 I L-chains. These data suggest that a second 
member of the PC VH gene family, Ylf, could 
theoretically be used to form PC-binding antibodies. 
Thus, the observation that most anti-PC antibodies 
use Vl or VI -derived sequences and not the Vl 1 
sequence cannot be attributed to the inherent inabil- 
ity of the V11 sequence to cooperate in formation of 
a PC-binding site. The question of why the VI1 
germhe sequence is not used to encode anti-PC 
antibodies cannot be answered simply. One likely 
possibility is that antibodies using Vl I sequences may 
have a much lower affinity for PC than those that use 
Vl sequences. This might be predicted from the 
observation that HPCG 15, which appears to use a 
non-VI sequence, has an affinity for PC which is 
IO-fold lower than most anti-PC antibodies (Gear- 
hart et ul., 1981). A second reason why Vl I germline 
sequences are not found in anti-PC antibodies may be 
that the VI I sequence does not pair e%ciently with 
the appropriate VK sequence. The precise sequence 
requirements for VH-VL pairing have not been 
established. In murine anti-PC antibodies, Rudikoff 
et a/. (1982) suggest that a glutamic acid residue at 
position 35 of the H-chain may interact with tyrosine 
at position 94 of the L-chain. These investigators 
noted that the VI gene is the only member of this VH 
fa,mily encoding glutamic acid at position 35. The fact 
that the VI 1 and V13 VH sequences have a glutamic 
acid residue to serine substitution at this position 
could affect the ability of these VH sequences to pair 
efficiently with an appropriate L-chain; however, this 
serine substitution occurs in the proteins HP6G6 and 
HPCG15, indicating that this substitution does not 
preclude H-L interaction. Preferential use of the VI 
gene product to encode anti-PC antibodies may 
reflect the importance of residue 35 in the structure 
of the PC-binding site. 
While our data show that the M47A chain is 
capable of forming a PC-binding site, they provide 
only limited information on the relative effectiveness 
of the Vi 1 germline sequence compared to Vl in 
formation of PC-binding antibodies. We observed 
that heterologous mixtures of M47A H-chain (VI 1) 
with HP6G6 L-chain showed less than 10:; of the 
PC-binding activity seen in a heterologous mixture of 
MS 11 H-chain (Vl) with the same L-chain. This 
lower binding activity, however, may be due to 
several factors. Chain recombination experiments 
involving the M47A H-chain are complicated by the 
fact that the M47A myeloma protein is an IgA 
half-mer (one H-chain and one L-chain), it lacks the 
CH3 H-chain domain and it contains an unusual 
covalent bond between the H- and L-chain (Mush- 
inski. I971; Robinson and Appella, 1979). The lack 
of a CH3 domain should not affect the ability of 
M47A H to pair with the L-chain since only VH-VK 
and CHI-CK interactions are involved in H--L pair- 
ing (Aiexandru ef (I/., 1980; Klein tt tri.. 1979). 
However, recombination involving the M47A H- 
chain would be expected to result in the formation of 
two-chain molecules rather than the usual four-chain 
molecules. In these experiments. we have not deter- 
mined whether the lower binding activity observed 
with M47A H-chain mixtures reflects less efficient 
H-L reassociation or the formation of a heterologous 
recombinant with a lower affinity for PC. It is likely 
that both decreased H-L pairing and lower affinity 
would be observed. The per cent H-L reassociation 
observed might be influenced by the stability of 
two-chain molecules and by possible trace amounts 
of homologous M47A L-chain in the M47A H-chain 
sample that could compete with heterologous L-chain 
(Grey and Mannik, 1965). The fact that M47A H and 
HP6G6 L recombinants exist as two-chain molecules 
should not affect the affinity of the binding site (Zack 
et al., 1981); however, monovalency may account for 
reduced binding observed in SRIA due to reduced 
avidity of these antibodies. Two-chain tnolecules 
cannot be affmity purified on PC-Sepharose (Zack r’! 
ai., 1981). Thus. we could not study the afiinity ol 
M47A H + HP6G6 L recombinant molecules or the 
idiotypic properties of this heterologous recombinant 
because we were unable to purify sufficient material 
for these experiments. 
Our data provide new information on the role of 
germline, somatic and combinatorial mechanisms in 
generating antibody diversity. The observation that 
the VII sequence could be used in anti-PC antibodies 
suggests that germline VH gene segments other than 
1/I may play a role in the immune response to PC. 
Other investigators have reported that PC-binding 
antibodies which use non-VI sequences (VH 13) can 
be found in Tl%suppressed mice (Kocher 6’1 II/.. 1980) 
and that a subset of T 15 idiotype-negative antibodies 
in the memory response to PC-KLH may use a VH 
sequence different from VI (Chang c~f 01.. I%-?: 
Wicker ef al., 1982). It would be interesting 10 
investigate whether suppression of antibodies which 
utilize VI-encoded sequences would result in the LISC' 
of the less common anti-PC antibodies from the VI 1 
gene or other VH genes. 
It is also possible that the germline VI/ sequence 
is not observed in the anti-PC response because 
substitutions in the V11 sequence (similar to that seen 
in HPCGl5 or HP6G6) may be required for the 
formation of a functional anti-PC antibody from this 
germline sequence. Somatic diversification has been 
suggested to account for increased affinity of I&i 
anti-PC antibodies (Rodwell c’t cri., 19X3). A similar 
finding has recently been reported for anti-arsonate 
antibodies (Rothstein and Gefter, 1983). It is possible 
that complementary substitutions in both VH and 
VL may be required for efficient PC-binding. 
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The role of combinatorial association in generating 
antibody diversity has been studied for many years. 
The chain recombination experiments presented here 
provide direct evidence for the role of combinatorial 
association in generating antibodies of different 
specificities. A single H-chain, M47A H, can pair 
with either M47A L or HP6G6 L to form antibodies 
with different specificities. Previous investigators 
have shown that the formation of functional anti- 
bodies through reassociation of heterologous H- and 
L.-chains is quite restricted (Bridges and Little, 1971; 
Grey and Mannik, 1965; Kranz and Voss, 1981; de 
Preval and Fougereau, 1976). Functional heterolo- 
gous recombinants have been formed between H- and 
L-chains derived from antibodies having highly ho- 
mologous amino acid sequences. For example, heter- 
ologous recombination among functionally-related 
antibodies such as anti-gaiactan (Manjula et al., 
1976), anti-inulin (Streefkerk et al., 1978) anti-H-2 
(Bluestone ef al., 1982) or anti-PC (Barstad et nl., 
1978; Hudak and Claflin. manuscript in preparation; 
Scher tt u(., 1971) antibodies can result in the for- 
mation of functional recombinant molecules. Re- 
cently. several observations have suggested that the 
same VI-I sequence may contribute to the formation 
of antibodies with different specificities. An example 
of overlapping VH repertoires may be seen in the 
anti-streptococcus group A carbohydrate antibody S8 
which has an N-terminal VH sequence very similar to 
the VI -encoded sequence of PC-binding antibodies 
(Capra et al.; 1976; Crews et ai., 1981). In addition, 
Staudt and Gerhard (1983) have recently reported 
that antibodies which bind the hemagglutinin {HA) 
protein of influenza may use sequences derived from 
the C’II VH gene. indicating that similar VH regions 
may be used by both anti-HA and anti-PC antibodies. 
By contrast, the VK sequences of anti-HA antibodies 
are very different from the VK sequences of anti-PC 
antibodies indicating that the L-chain is critical in 
determining specificity of these antibodies. Previous 
studies (Leon and Young, 1971; Andres et al., 1981, 
Hudak and Claflin. manuscript in preparation) have 
shown a correlation between L-chain type and fine 
specificity of PC-binding. The L-chain may contribute 
some contact residues or L-chain may influence con- 
formation of the H-chain and thus dictate specificity 
indirectly (Kabat, 1981). Chain recombination experi- 
ments between anti-HA antibodies and anti-PC anti- 
bodies may prove useful in further delineating the role 
of combinatorial association in generating antibody 
diversity. 
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